“…In this pioneering in vitro work, the role of targeted AuNps as sonosensitizers in SDT, an innovative anticancer approach where, it is generally accepted, a non-toxic molecule or system (chemical actuator), i.e., the sonosensitizer, is activated by US (physical activator), yielding oxidative damage by ROS generation, and consequent cancer cell death [94,95]. More specifically, the authors suggest that US, used at the frequency of 1.866 MHz for a total 5 min of exposure, through a physical phenomenon called sonoluminescence [96], might drive the AuNPs' plasmonic effect, as derived from LSPR, to be able to convert the photon energy to heat in order to induce cellular damage via ROS production. Analysis of intracellular ROS production was investigated in two different cell lines, HCT-116 and KB, and demonstrated that, while cells incubated with AuNPs in the absence of US and US alone did not encounter an increase in intracellular ROS productions, cells that were exposed to both AuNPs and US, i.e., sonodynamic treatment, were subjected to a significant increase in ROS production and therefore enhanced death rates.…”